Insider trade

Officer sold ~$214K of BIO shares in the open market

Traded Nov 6, 2025 · Filed Nov 10, 2025

Why it stands out

Bio-Rad Laboratories's President, LSG sold $214K of Bio-Rad Laboratories shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$100K–$500K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$214,289

Shares × reported transaction price

Timing vs results

8 days after results of Oct 29, 2025, 98 days before results of Feb 12, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−1.8%	−3.4%	+1.6%
30 days	+0.2%	+0.9%	−0.7%
90 days	−5.9%	+1.6%	−7.5%
180 days	−22.2%	+8.2%	−30.4%

Past results only. Not a forecast.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.104 to $306.230, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.